Horsham, Pa. (PRWEB) June 21, 2013
DIA executives will hold a news conference on issues confronting the fields of medical product development and therapeutic innovation at the DIA 2013 49th Annual Meeting in Boston on June 24. The discussion will highlight findings from a survey of 442 stakeholders, representing all pillars of the drug and medical device development arena. Executives will speak and take questions from reporters at 11:30 a.m.
The conference will feature Dr. Ling Su, DIA president; Minnie Baylor-Henry, DIA president-elect; Susan Cantrell, director of DIA North America; and Carlos Fulcher, DIA deputy executive director.
The DIA 2013 49th Annual Meeting brings together a community of professionals across all disciplines in the discovery, development and life cycle management of medical products to collaborate and advance therapeutic innovation and regulatory science.
WHAT: DIA Executive News Conference
WHEN: Monday, June 24, 11:30 a.m.
WHERE: Room 207, Boston Convention & Exhibition Center, 415 Summer St., Boston
ABOUT DIA: DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well-being worldwide. Headquarters are in Horsham, Pa., USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; Beijing, China; Washington, D.C.; and Latin America. Visit our website at http://www.diahome.org and follow DIA at: LinkedIn, Twitter, YouTube, Facebook, Flickr and Pinterest.